Clinical Trials Using EGFR/HER2 Mutant-selective Inhibitor BH-30643
Review the clinical trials studying egfr/her2 mutant-selective inhibitor bh-30643 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- Status: ActiveLocation: 12 locations